Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer

KRAS mutations are a major cause of drug resistance to molecular-targeted therapies. Aberrant epidermal growth factor receptor (EGFR) signaling may cause dysregulation of microRNA (miRNA) and gene regulatory networks, which leads to cancer initiation and progression. To address the functional releva...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mol Ther Nucleic Acids
Главные авторы: Hiraki, Masayuki, Nishimura, Junichi, Takahashi, Hidekazu, Wu, Xin, Takahashi, Yusuke, Miyo, Masaaki, Nishida, Naohiro, Uemura, Mamoru, Hata, Taishi, Takemasa, Ichiro, Mizushima, Tsunekazu, Soh, Jae-Won, Doki, Yuichiro, Mori, Masaki, Yamamoto, Hirofumi
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2015
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354340/
https://ncbi.nlm.nih.gov/pubmed/25756961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtna.2015.5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы